INADEQUATE RESPONSE TO INDUCTION CHEMOTHERAPY IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA: AN INSTITUTIONAL

被引：0
|
作者：
Schrey, D. [1 ]
Vaidya, S. [1 ]
Levine, D. [1 ]
Moreno, L. [1 ]
Pearson, A. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] The Impact of Improving Nutrition During Induction Chemotherapy in Children with High-Risk Neuroblastoma
    Carroll, C.
    Smith, A.
    Clinton, F.
    Ryan, A.
    Capra, M.
    Pears, J.
    Owens, C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S288 - S288
  • [2] The evaluation of induction chemotherapy regimens for high-risk neuroblastoma in South African children*
    Van Heerden, Jaques
    Geel, Jennifer
    Hendricks, Marc
    Wouters, Kristien
    Buchner, Ane
    Naidu, Gita
    Hadley, G. P.
    Du Plessis, Jan
    Van Emmenes, Barry
    Van Zyl, Anel
    Vermeulen, Johani
    Kruger, Mariana
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (04) : 300 - 313
  • [3] Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma
    Elwira Szychot
    Daniel Morgenstern
    Mark Chopra
    Stefania Sorrentino
    Owen Arthurs
    Neil Sebire
    Farrukh Arfeen
    Andrzej Brodkiewicz
    Paul Humphries
    Lorenzo Biassoni
    International Journal of Clinical Oncology, 2022, 27 : 253 - 261
  • [4] Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma
    Szychot, Elwira
    Morgenstern, Daniel
    Chopra, Mark
    Sorrentino, Stefania
    Arthurs, Owen
    Sebire, Neil
    Arfeen, Farrukh
    Brodkiewicz, Andrzej
    Humphries, Paul
    Biassoni, Lorenzo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (01) : 253 - 261
  • [5] A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
    Herd, Fiona
    Basta, Nermine O.
    McNally, Richard J. Q.
    Tweddle, Deborah A.
    EUROPEAN JOURNAL OF CANCER, 2019, 111 : 50 - 58
  • [6] Predictors of differential outcomes according to response to induction chemotherapy in high-risk neuroblastoma.
    Sokol, Elizabeth
    LaBarre, Brian
    Naranjo, Arlene
    Pinto, Navin R.
    Kreissman, Susan G.
    Granger, Meaghan
    Park, Julie R.
    Bagatell, Rochelle
    DuBois, Steven G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma
    Jiaxi Du
    Xiaojun Yuan
    European Journal of Pediatrics, 2024, 183 : 185 - 202
  • [8] Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma
    Du, Jiaxi
    Yuan, Xiaojun
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (01) : 185 - 202
  • [9] Induction for high-risk neuroblastoma
    Kushner, Brian H.
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 221 - 223
  • [10] Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
    Pinto, Navin R.
    Hibbitts, Emily
    Kreissman, Susan G.
    Granger, Meaghan P.
    Irwin, Meredith
    Bagatell, Rochelle
    London, Wendy B.
    Greengard, Emily Gustava
    Naranjo, Arlene
    Park, Julie R.
    DuBois, Steven G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345